Tweet
20% INCREASE IN INFANT TREATABILITY OBSERVED OVER 2 YEARS DUE TO NEONATAL CARE PROJECT
PanARMENIAN.Net
June 9, 2011 - 20:07 AMT
PanARMENIAN.Net - The results of long-term national project on Neonatal
Care implemented by VivaCell-MTS and BirthLink were summed up during
Yerevan-hosted conference.
The conference brought together doctors and nurses throughout Armenia,
involved in the Neonatal Care project. The conference was part of the
long-term cooperation between VivaCell-MTS and UK-based BirthLink to
improve the care of sick and vulnerable newborn babies in Armenia.
Kathy Mellor, Director of BirthLink, and Dr. Hrant Kalenterian,
Chief Neonatologist of Armenia, presented an overview of the project
to date and assessed the achievements of the first two years.
"Project results are quite encouraging: infant mortality rate dropped
from 16% to 11%," VivaCell-MTS General Manager Ralph Yirikian noted.
"With good facilities and equipment, complemented by a program of
continuous education and a sound medical knowledge, many of these
deaths are preventable as proven by international experience. We are
happy that this massive social investment has proven to be justified,"
Mr. Yirikian stressed.
In 2008 through 2010, 11 neonatal departments in Yerevan and 7
departments in Armenian regions were provided with AMD 359 million
worth equipment.
In 2011, the second phase of the project will be implemented, focusing
on more neonatal centers in the regions, where newborn babies with
complications can be transferred to from maternity hospitals, for
ongoing care.
"Infant mortality is not only a medical issue, it has social aspects
as well. Both medical equipment and knowledge of doctors help to solve
mortality issues. In past several years, many investments were made
in Armenia. Over the last 2 years, the rate of infant treatability
increased by 20%. Infants who were previously moved to 3rd level
clinics are today getting treated onsite, with infant mortality rate
reduced by 20%," Dr. Kalenterian said.
From: Baghdasarian
PanARMENIAN.Net
June 9, 2011 - 20:07 AMT
PanARMENIAN.Net - The results of long-term national project on Neonatal
Care implemented by VivaCell-MTS and BirthLink were summed up during
Yerevan-hosted conference.
The conference brought together doctors and nurses throughout Armenia,
involved in the Neonatal Care project. The conference was part of the
long-term cooperation between VivaCell-MTS and UK-based BirthLink to
improve the care of sick and vulnerable newborn babies in Armenia.
Kathy Mellor, Director of BirthLink, and Dr. Hrant Kalenterian,
Chief Neonatologist of Armenia, presented an overview of the project
to date and assessed the achievements of the first two years.
"Project results are quite encouraging: infant mortality rate dropped
from 16% to 11%," VivaCell-MTS General Manager Ralph Yirikian noted.
"With good facilities and equipment, complemented by a program of
continuous education and a sound medical knowledge, many of these
deaths are preventable as proven by international experience. We are
happy that this massive social investment has proven to be justified,"
Mr. Yirikian stressed.
In 2008 through 2010, 11 neonatal departments in Yerevan and 7
departments in Armenian regions were provided with AMD 359 million
worth equipment.
In 2011, the second phase of the project will be implemented, focusing
on more neonatal centers in the regions, where newborn babies with
complications can be transferred to from maternity hospitals, for
ongoing care.
"Infant mortality is not only a medical issue, it has social aspects
as well. Both medical equipment and knowledge of doctors help to solve
mortality issues. In past several years, many investments were made
in Armenia. Over the last 2 years, the rate of infant treatability
increased by 20%. Infants who were previously moved to 3rd level
clinics are today getting treated onsite, with infant mortality rate
reduced by 20%," Dr. Kalenterian said.
From: Baghdasarian